These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A dystrophin-associated glycoprotein, A3a (one of 43DAG doublets), is retained in Duchenne muscular dystrophy muscle. Yoshida M; Mizuno Y; Nonaka I; Ozawa E J Biochem; 1993 Nov; 114(5):634-9. PubMed ID: 8113213 [TBL] [Abstract][Full Text] [Related]
43. Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines. Nguyen TM; Ellis JM; Love DR; Davies KE; Gatter KC; Dickson G; Morris GE J Cell Biol; 1991 Dec; 115(6):1695-700. PubMed ID: 1757469 [TBL] [Abstract][Full Text] [Related]
44. Mini- and full-length dystrophin gene transfer induces the recovery of nitric oxide synthase at the sarcolemma of mdx4cv skeletal muscle fibers. Decrouy A; Renaud JM; Lunde JA; Dickson G; Jasmin BJ Gene Ther; 1998 Jan; 5(1):59-64. PubMed ID: 9536265 [TBL] [Abstract][Full Text] [Related]
45. Altered alpha1-syntrophin expression in myofibers with Duchenne and Fukuyama muscular dystrophies. Wakayama Y; Inoue M; Kojima H; Jimi T; Yamashita S; Kumagai T; Shibuya S; Hara H; Oniki H Histol Histopathol; 2006 Jan; 21(1):23-34. PubMed ID: 16267784 [TBL] [Abstract][Full Text] [Related]
46. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. Ohlendieck K; Campbell KP J Cell Biol; 1991 Dec; 115(6):1685-94. PubMed ID: 1757468 [TBL] [Abstract][Full Text] [Related]
47. Dystrophin-glycoprotein complex and laminin colocalize to the sarcolemma and transverse tubules of cardiac muscle. Klietsch R; Ervasti JM; Arnold W; Campbell KP; Jorgensen AO Circ Res; 1993 Feb; 72(2):349-60. PubMed ID: 8418988 [TBL] [Abstract][Full Text] [Related]
48. The cardiomyopathy of Duchenne's muscular dystrophy and the function of dystrophin. Cziner DG; Levin RI Med Hypotheses; 1993 Mar; 40(3):169-73. PubMed ID: 8502196 [TBL] [Abstract][Full Text] [Related]
49. Quantification of dystrophin immunofluorescence in dystrophinopathy muscle specimens. Taylor LE; Kaminoh YJ; Rodesch CK; Flanigan KM Neuropathol Appl Neurobiol; 2012 Oct; 38(6):591-601. PubMed ID: 22243335 [TBL] [Abstract][Full Text] [Related]
50. Are cysteine-rich and COOH-terminal domains of dystrophin critical for sarcolemmal localization? Récan D; Chafey P; Leturcq F; Hugnot JP; Vincent N; Tomé F; Collin H; Simon D; Czernichow P; Nicholson LV J Clin Invest; 1992 Feb; 89(2):712-6. PubMed ID: 1737859 [TBL] [Abstract][Full Text] [Related]
51. Contractile function, sarcolemma integrity, and the loss of dystrophin after skeletal muscle eccentric contraction-induced injury. Lovering RM; De Deyne PG Am J Physiol Cell Physiol; 2004 Feb; 286(2):C230-8. PubMed ID: 14522817 [TBL] [Abstract][Full Text] [Related]
52. [Duchenne's myodystrophy--a hereditary defect of the cell membranes]. Khrennikov VIu Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(3):22-4. PubMed ID: 1646530 [TBL] [Abstract][Full Text] [Related]
53. Perspective: Spectrin-Like Repeats in Dystrophin Have Unique Binding Preferences for Syntrophin Adaptors That Explain the Mystery of How nNOSμ Localizes to the Sarcolemma. Percival JM Front Physiol; 2018; 9():1369. PubMed ID: 30349485 [TBL] [Abstract][Full Text] [Related]
54. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Cox GA; Sunada Y; Campbell KP; Chamberlain JS Nat Genet; 1994 Dec; 8(4):333-9. PubMed ID: 7894482 [TBL] [Abstract][Full Text] [Related]
55. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Petrof BJ; Shrager JB; Stedman HH; Kelly AM; Sweeney HL Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3710-4. PubMed ID: 8475120 [TBL] [Abstract][Full Text] [Related]
56. Caveolin-3 is not an integral component of the dystrophin glycoprotein complex. Crosbie RH; Yamada H; Venzke DP; Lisanti MP; Campbell KP FEBS Lett; 1998 May; 427(2):279-82. PubMed ID: 9607328 [TBL] [Abstract][Full Text] [Related]
57. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. Mendell JR; Kissel JT; Amato AA; King W; Signore L; Prior TW; Sahenk Z; Benson S; McAndrew PE; Rice R N Engl J Med; 1995 Sep; 333(13):832-8. PubMed ID: 7651473 [TBL] [Abstract][Full Text] [Related]
59. Dystrophin immunostaining and freeze-fracture studies of muscles of patients with early stage amyotrophic lateral sclerosis and Duchenne muscular dystrophy. Wakayama Y; Jimi T; Misugi N; Kumagai T; Miyake S; Shibuya S; Miike T J Neurol Sci; 1989 Jun; 91(1-2):191-205. PubMed ID: 2664093 [TBL] [Abstract][Full Text] [Related]
60. Immunofluorescence dystrophin study in Duchenne dystrophy through the concomitant use of two antibodies directed against the carboxy-terminal and the amino-terminal region of the protein. Vainzof M; Zubrzycka-Gaarn EE; Rapaport D; Passos-Bueno MR; Pavanello RC; Pavanello-Filho I; Zatz M J Neurol Sci; 1991 Feb; 101(2):141-7. PubMed ID: 1709683 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]